Gujarat Kidney & Super Speciality IPO
IPO लिस्टिंग का विवरण
- लिस्टिंग की तिथि
30 दिसंबर 2025
- लिस्टिंग की कीमत
₹120.75
- लिस्टिंग में बदलाव
5.92%
- अंतिम ट्रेडेड कीमत
₹128.42
Gujarat Kidney & Super Speciality IPO Details
-
खुलने की तिथि
22 दिसंबर 2025
-
समाप्ति तिथि
24 दिसंबर 2025
- IPO प्राइस रेंज
₹108 से ₹114
- IPO साइज़
₹ 250.80 करोड़
Gujarat Kidney & Super Speciality IPO Timeline
Gujarat Kidney & Super Speciality IPO Subscription Status
| तिथि | क़िब | एनआईआई | खुदरा | कुल |
|---|---|---|---|---|
| 22-Dec-2025 | 0.34 | 1.97 | 4.75 | 1.48 |
| 23-Dec-2025 | 0.34 | 2.95 | 10.46 | 2.68 |
| 24-Dec-2025 | 1.06 | 5.72 | 18.91 | 5.19 |
अंतिम अपडेट: 24 दिसंबर 2025 5:24 PM तक 5paisa
Gujarat Kidney and Super Speciality Limited (GKASSL) delivers multispeciality healthcare across Gujarat, India, operating seven hospitals and four pharmacies with 490 beds (455 approved, 340 operational). Its facilities include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre and Store (Anand). Services span secondary care, general and surgical treatments, and tertiary care, including super-speciality procedures in medicine, surgery, orthopaedics, cardiology, diabetology, obstetrics, gynaecology, and anaesthesiology.
स्थापित: 2019
मैनेजिंग डायरेक्टर: डॉ. प्रग्नेश यशवंतसिंह भारपोडा
सहकर्मी:
| मेट्रिक | Gujarat Kidney Limited |
Yatharth Hospital & Trauma Care Services Limited |
GPT Healthcare Limited |
केएमसी स्पेशियलिटी होस्पिटल्स ( इन्डीया ) लिमिटेड |
|
वर्तमान मार्केट प्राइस (CMP) |
[●] | 822 | 149 | 69 |
| फेस वैल्यू (₹ प्रति शेयर) | 2 | 10 | 10 | 1 |
| ऑपरेशन से राजस्व (₹ करोड़) | 119.97 | 880.49 | 407.09 | 231.60 |
| Earnings Per Share (Basic & Diluted) (₹) | 2.89 | 14.72 | 6.08 | 1.31 |
|
नव |
7.53 | 166.62 | 30.21 | 10.08 |
|
पैट |
12.61 | 14.83 | 12.26 | 9.225 |
| पी/ई | [●] | 55.84 | 24.51 | 52.60 |
| Return on Net Worth (RoNW) (%) | 38.38 | 8.13 | 20.14 | 13.04 |
Gujarat Kidney & Super Speciality Objectives
1. The company proposes acquisition of Parekhs Hospital, Ahmedabad for ₹77.00 crore.
2. It plans part-payment for Ashwini Medical Centre acquisition, ₹12.40 crore.
3. Funds will support capital expenditure for a new Vadodara hospital, ₹30.10 crore.
4. The company intends to buy robotics equipment for Vadodara hospital, ₹6.83 crore.
5. Full or part repayment of secured borrowings is planned, ₹1.20 crore.
6. It aims to fund inorganic growth through unidentified acquisitions and general corporate purposes.
7. The company seeks additional shares in Harmony Medicare Private Limited, Bharuch, ₹10.78 crore.
Gujarat Kidney IPO Size
| प्रकार | आकार |
|---|---|
| कुल IPO साइज़ | ₹ 250.80 करोड़ |
| ऑफर फॉर सेल | - |
| नई समस्या | ₹ 250.80 करोड़ |
Gujarat Kidney IPO Lot Size
| अनुप्रयोग | लॉट्स | शेयर | राशि (₹) |
|---|---|---|---|
| रिटेल (न्यूनतम) | 1 | 128 | 13,824 |
| रिटेल (अधिकतम) | 13 | 1,664 | 1,79,712 |
| एस-एचएनआई (न्यूनतम) | 14 | 1,792 | 1,93,536 |
| S-HNI (अधिकतम) | 68 | 8,704 | 9,92,256 |
| बी-एचएनआई (न्यूनतम) | 69 | 8,832 | 9,53,856 |
Gujarat Kidney IPO Reservation
| निवेशकों की कैटेगरी | सब्सक्रिप्शन (बार) | ऑफर किए गए शेयर* | शेयर बिड के लिए | कुल राशि (करोड़)* |
|---|---|---|---|---|
| क्यूआईबी (एक्स एंकर) | 1.06 | 77,26,880 | 81,88,928 | 93.35 |
| नॉन-इंस्टीट्यूशनल खरीदार | 5.72 | 33,00,000 | 1,88,85,504 | 215.29 |
| bNII (₹10 लाख से अधिक की बिड) | 5.25 | 22,00,000 | 1,15,52,896 | 131.70 |
| sNII (₹10 लाख से कम की बिड) | 6.67 | 11,00,000 | 73,32,608 | 83.59 |
| इंडिविजुअल इन्वेस्टर्स (2 लॉट्स के लिए इंड कैटेगरी बिडिंग) | 18.91 | 22,00,000 | 4,16,06,784 | 474.32 |
| कुल** | 5.19 | 1,32,26,880 | 6,86,81,216 | 782.97 |
*"ऑफर किए गए शेयर" और "कुल राशि" की गणना जारी की गई कीमत रेंज की ऊपरी लिमिट का उपयोग करके की जाती है.
**एंकर इन्वेस्टर (या मार्केट मेकर) को आवंटित शेयरों को ऑफर किए गए कुल शेयरों की संख्या से बाहर रखा जाता है.
| विवरण (₹ करोड़ में) | FY23 | FY24 | FY25 |
| राजस्व | - | 4.77 | 40.24 |
| EBITDA | -0.00 | 1.95 | 16.55 |
| पैट | -0.00 | 1.71 | 9.50 |
| विवरण (₹ करोड़ में) | FY23 | FY24 | FY25 |
| कुल एसेट | 3.87 | 20.53 | 55.34 |
| शेयर कैपिटल | 0.20 | 0.20 | 11.37 |
| कुल देयताएं | 3.50 | 9.72 | 28.22 |
| कैश फ्लो (₹ करोड़) | FY23 | FY24 | FY25 |
| ऑपरेटिंग गतिविधियों से/(इस्तेमाल की गई) नेट कैश जनरेट किया गया है | 0.00 | 1.21 | 13.61 |
| निवेश गतिविधियों से/(इस्तेमाल में) जनरेट की गई नेट कैश | - | 0.22 | -18.14 |
| फाइनेंसिंग गतिविधियों से/(इस्तेमाल की गई) नेट कैश जनरेट किया गया है | - | -0.47 | 6.16 |
| कैश और कैश के बराबर में शुद्ध वृद्धि (कम) | 0.00 | 0.97 | 1.63 |
शक्तियां
1. Operates seven multispeciality hospitals across Gujarat.
2. Offers both secondary and tertiary care services.
3. Strong presence in Vadodara and key cities.
4. Wide range of super-speciality medical treatments.
कमजोरियां
1. Operational bed capacity below total approved beds.
2. Limited presence outside Gujarat reduces market reach.
3. High dependence on hospital revenue streams.
4. Capital-intensive expansions may strain finances.
अवसर
1. Proposed acquisition of Parekhs Hospital, Ahmedabad.
2. Expansion into robotics and advanced medical equipment.
3. Potential for inorganic growth through acquisitions.
4. Rising healthcare demand in Gujarat region.
धमकियां
1. Competition from other multispeciality hospitals nearby.
2. Regulatory changes could impact hospital operations.
3. Economic downturn may reduce patient affordability.
4. Dependence on skilled professionals for specialised services.
1. Strong presence across multiple cities in Gujarat.
2. Expanding super-speciality services and advanced treatment facilities.
3. Strategic acquisitions enhance growth and market reach.
4. Robust potential from rising regional healthcare demand.
Gujarat Kidney and Super Speciality Limited operates in a rapidly growing healthcare market in Gujarat. With seven hospitals and four pharmacies, it addresses increasing demand for secondary and tertiary care. Expanding services in super-specialities, robotics, and new hospital setups enhance its growth prospects. Strategic acquisitions and modern infrastructure position the company to capture a larger patient base, strengthen regional presence, and benefit from rising healthcare awareness and spending.
FAQ
Gujarat Kidney IPO opens from December 22, 2025 to December 24, 2025.
The size of Gujarat Kidney IPO is ₹250.80.
The price band of Gujarat Kidney IPO is fixed at ₹108 to ₹114.
To apply for Gujarat Kidney IPO, follow the steps given below:
● अपने 5paisa डीमैट अकाउंट में लॉग-इन करें और मौजूदा IPO सेक्शन में समस्या चुनें
● Enter the number of lots and the price at which you wish to apply for the Gujarat Kidney. IPO.
● अपनी UPI ID दर्ज करें और सबमिट पर क्लिक करें. इसके साथ, आपकी बिड एक्सचेंज के साथ दी जाएगी.
आपको अपनी UPI ऐप में फंड ब्लॉक करने के लिए मैंडेट नोटिफिकेशन प्राप्त होगा.
The minimum lot size of Gujarat Kidney IPO is of 128 shares and the investment required is ₹13,824.
The share allotment date of Gujarat Kidney IPO is December 26, 2025
The Gujarat Kidney IPO will likely be listed on December 30, 2025.
Nirbhay Capital Services Pvt.Ltd is the book running lead managers for Gujarat Kidney IPO.
Gujarat Kidney IPO plans to utilise the raised capital from the IPO for:
1. The company proposes acquisition of Parekhs Hospital, Ahmedabad for ₹77.00 crore.
2. It plans part-payment for Ashwini Medical Centre acquisition, ₹12.40 crore.
3. Funds will support capital expenditure for a new Vadodara hospital, ₹30.10 crore.
4. The company intends to buy robotics equipment for Vadodara hospital, ₹6.83 crore.
5. Full or part repayment of secured borrowings is planned, ₹1.20 crore.
6. It aims to fund inorganic growth through unidentified acquisitions and general corporate purposes.
7. The company seeks additional shares in Harmony Medicare Private Limited, Bharuch, ₹10.78 crore.